Identification of Two Novel Regulatory Genes Involved in Pristinamycin Biosynthesis and Elucidation of the Mechanism for AtrA-p-mediated Regulation in Streptomyces Pristinaespiralis
Wenfang Wang,Jinzhong Tian,Lei Li,Mei Ge,Hong Zhu,Guosong Zheng,He Huang,Lijun Ruan,Weihong Jiang,Yinhua Lu
DOI: https://doi.org/10.1007/s00253-015-6638-6
IF: 5
2015-01-01
Applied Microbiology and Biotechnology
Abstract:In this study, using a transposon-based strategy, two novel regulatory genes were identified as being involved in the biosynthesis of both pristinamycin I (PI) and II (PII) in Streptomyces pristinaespiralis , including a TetR-family regulatory gene atrA -p ( SSDG _ 00466 ) and an orphan histidine kinase gene SSDG _ 02492 . The mechanism by which AtrA-p exerted a positive role in pristinamycin production was elucidated. We showed that deletion of atrA - p resulted in a delayed production of both PI and PII as well as reduced PII production. Transcriptional analysis integrated with electrophoretic mobility shift assays (EMSAs) demonstrated that AtrA-p played a positive role in pristinamycin production by directly activating the transcription of two cluster-situated regulatory genes, spbR and papR5 , which encode a γ-butyrolactone receptor protein and a TetR-family repressor, respectively. The precise AtrA-p-binding sites upstream of these two targets were determined, which allowed the identification of a relatively conserved binding motif comprising two 5-nt inverted repeats separated by a variable 5-nt sequence (5′-GGAAT-n 5 -ATTCC-3′) possibly required for the regulation of AtrA-like regulators in Streptomyces . Base substitutions of the AtrA-p-binding sites on the genome caused similar decreases in spbR and papR5 transcription as those observed in ∆ atrA - p . Taken together, herein, a novel mechanism for AtrA-dependent regulation of antibiotic biosynthesis was revealed in S. pristinaespiralis , which is distinct from those of its homologs, AtrA-c from Streptomyces coelicolor , AtrA-g from Streptomyces griseus , and AtrA from Streptomyces roseosporus that perform their effects in antibiotic biosynthesis directly via pathway-specific activator genes or the biosynthetic structural genes.